Technology
Health
Biotechnology

Histogenics

$0.125
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0063 (-4.96%) Today
+$0.0042 (3.48%) After Hours

Why Robinhood?

You can buy or sell Histogenics and other stocks, options, ETFs, and crypto commission-free!

About

Histogenics Corp. engages in the development, marketing, and commercialization of musculoskeletal medicine. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. Read More The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

Employees
45
Headquarters
Waltham, Massachusetts
Founded
2000
Market Cap
4.23M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
4.13M
High Today
$0.129
Low Today
$0.12
Open Price
$0.1278
Volume
2.30M
52 Week High
$3.05
52 Week Low
$0.08

Collections

Technology
Health
Biotechnology
Medical
Advertising and Marketing
Engineering
Business Services
2014 IPO

Earnings

-$0.52
-$0.37
-$0.21
-$0.06
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.06 per share
Actual
Expected Mar 28, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.